Obesity, inflammation, and cancer
Obesity, a worldwide epidemic, confers increased risk for multiple serious conditions,
including cancer, and is increasingly recognized as a growing cause of preventable cancer …
including cancer, and is increasingly recognized as a growing cause of preventable cancer …
Interleukin-6 and its receptors: a highly regulated and dynamic system
J Wolf, S Rose-John, C Garbers - Cytokine, 2014 - Elsevier
Abstract Interleukin-6 (IL-6) is a multifunctional cytokine with well-defined pro-and anti-
inflammatory properties. Although only small amounts in the picogram range can be …
inflammatory properties. Although only small amounts in the picogram range can be …
Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct IL6-mediated therapy resistance in pancreatic cancer
The tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC) involves a
significant accumulation of fibroblasts as part of the host response to cancer. Using single …
significant accumulation of fibroblasts as part of the host response to cancer. Using single …
Autophagy, inflammation, and immune dysfunction in the pathogenesis of pancreatitis
Pancreatitis is a common disorder with significant morbidity and mortality, yet little is known
about its pathogenesis, and there is no specific or effective treatment. Its development …
about its pathogenesis, and there is no specific or effective treatment. Its development …
[HTML][HTML] Pathogenic mechanisms of pancreatitis
M Manohar, AK Verma, SU Venkateshaiah… - World journal of …, 2017 - ncbi.nlm.nih.gov
Pancreatitis is inflammation of pancreas and caused by a number of factors including
pancreatic duct obstruction, alcoholism, and mutation in the cationic trypsinogen gene …
pancreatic duct obstruction, alcoholism, and mutation in the cationic trypsinogen gene …
[HTML][HTML] The cause and effect relationship of diabetes after acute pancreatitis
M Śliwińska-Mossoń, I Bil-Lula, G Marek - Biomedicines, 2023 - mdpi.com
Acute pancreatitis (AP) is an acute inflammation of the pancreas associated with high
morbidity and mortality. Endocrine pancreatic insufficiency secondary to AP has drawn …
morbidity and mortality. Endocrine pancreatic insufficiency secondary to AP has drawn …
Curcumin: An effective inhibitor of interleukin-6
M Ghandadi, A Sahebkar - Current pharmaceutical design, 2017 - ingentaconnect.com
Curcumin is apolyphenolic cominflammatory effects of curcumin. Moreover, curcumin can be
considered as potential therapy against IL-6 involvepound found in the dietary spice …
considered as potential therapy against IL-6 involvepound found in the dietary spice …
Emerging roles for the IL-6 family of cytokines in pancreatic cancer
G van Duijneveldt, MDW Griffin, TL Putoczki - Clinical science, 2020 - portlandpress.com
Pancreatic cancer has one of the poorest prognoses of all malignancies, with little
improvement in clinical outcome over the past 40 years. Pancreatic ductal adenocarcinoma …
improvement in clinical outcome over the past 40 years. Pancreatic ductal adenocarcinoma …
[HTML][HTML] Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
N Vainer, C Dehlendorff, JS Johansen - Oncotarget, 2018 - ncbi.nlm.nih.gov
Gastrointestinal cancer (GI) is a major health problem. Patients with gastric, pancreatic,
colorectal, bile duct and gall bladder cancer often have advanced disease at the time of …
colorectal, bile duct and gall bladder cancer often have advanced disease at the time of …
Molecular and cellular mechanisms of chemoresistance in pancreatic cancer
A Adamska, O Elaskalani, A Emmanouilidi… - Advances in biological …, 2018 - Elsevier
Abstract Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most chemoresistant
cancers, and current therapies targeting cancer-associated molecular pathways have not …
cancers, and current therapies targeting cancer-associated molecular pathways have not …